Scinovex
review Open AccessTop 10% cited

SARS: Systematic Review of Treatment Effects

PLoS Medicine · 2006 · Vol. 3(9) · pp. e343–e343
Lauren J. StockmanRichard BellamyPaul Garner

Abstract

Despite an extensive literature reporting on SARS treatments, it was not possible to determine whether treatments benefited patients during the SARS outbreak. Some may have been harmful. Clinical trials should be designed to validate a standard protocol for dosage and timing, and to accrue data in real time during future outbreaks to monitor specific adverse effects and help inform treatment.

MeSH terms

Disease OutbreaksHumansSevere Acute Respiratory SyndromeSevere acute respiratory syndrome-related coronavirus

Funding

  • Department for International Development
  • Centers for Disease Control and Prevention
Citations
1,268
FWCI
6.93
field-weighted impact
References
31
Percentile
98%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

SARS: Systematic Review of Treatment Effects · Scinovex